Cumberland Pharmaceuticals Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Grand Canyon Education places CFO on leave amid stock trade probe
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.04
August 2, 2016 6:00 PM EDTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.04, versus $0.09 reported last year. Revenue for the quarter came in at $7.4 million, versus $8.9 million reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More